Demonstrates synthesis of urolithin A glucuronides, indicating a new approach for metabolic studies.
Urolithins, 6 H -dibenzo[ b,d ]pyran-6-one derivatives, are metabolites produced by gut microbiota from ellagic acid, a natural antioxidant. They are more efficiently absorbed than ellagic acid and contribute to the health benefits of ellagitannin-rich foods. Among these, urolithin A (UA) and its conjugated metabolites play key roles in biological activity and pharmacokinetics. Access to structurally defined UA glucuronides is therefore important for metabolic and functional studies. Here, we describe a framework-assembly approach to the total synthesis of UA 3- and 8-glucuronides, in which the urolithin scaffold is constructed via a palladium-mediated intramolecular biaryl coupling of a phenyl benzoate precursor. The coupling step provides a predominant regioisomer together with a minor isomer, which can be separated to furnish a structurally defined intermediate. Subsequent orthogonal protection-deprotection sequences and Schmidt glycosylation enable the preparation of UA 3- and 8-glucuronides as individual regioisomers in pure form. This strategy offers an alternative route to well-defined UA metabolites and provides a platform for the synthesis of diverse urolithin derivatives relevant to studies of metabolism, gut microbiota interactions, and therapeutic potential. • Urolithin A glucuronide derivatives were synthesised by Pd-mediated intramolecular biaryl coupling reaction. • By selecting appropriate protecting groups, we succeeded in the selective synthesis of two regioisomers.
No takes yet. Share an insight, caveat, or question.
Nagai et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: